Brief: Proteostasis Stockholders Approve Business Combination With Yumanity Therapeutics

Kineta

22/12/2020 16:20

Dec 22 (Reuters) - Proteostasis Therapeutics Inc  PTI.O :
    * PROTEOSTASIS THERAPEUTICS, INC. STOCKHOLDERS APPROVE
BUSINESS
COMBINATION WITH YUMANITY THERAPEUTICS, INC.; BOARD SETS REVERSE
STOCK SPLIT RATIO
    * PROTEOSTASIS THERAPEUTICS INC - DETERMINED TO EFFECT A
REVERSE
STOCK SPLIT OF PROTEOSTASIS COMMON STOCK AT A RATIO OF 1-FOR-20
    * REVERSE STOCK SPLIT IS EXPECTED TO BECOME EFFECTIVE AT
12:00
P.M. EASTERN TIME ON DECEMBER 22, 2020
    * ASSUMING EFFECTIVENESS OF REVERSE STOCK SPLIT AND CLOSING
OF
MERGER, PROTEOSTASIS WILL BE RENAMED YUMANITY THERAPEUTICS, INC.
    * YUMANITY'S STOCK WILL COMMENCE TRADING ON NASDAQ CAPITAL
MARKET
ON POST-REVERSE STOCK SPLIT BASIS UNDER NEW SYMBOL "YMTX" ON,
DEC 23

Source text for Eikon:  urn:newsml:reuters.com:*:nPn1WV5Bna
Further company coverage:  PTI.O 

 ((Reuters.Briefs@thomsonreuters.com;))